At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 50 enrolled
Drug / intervention
Otezladrug
Likely dose
Otezla 30mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single Center Study to Evaluate the Effectiveness and Safety of Add on Enstilar® in Patients Using OTEZLA® for Moderate to Severe Plaque Psoriasis
Psoriasis Treatment Center of Central New Jersey·interventional·Posted Jul 16, 2018·Updated Apr 16, 2024
In Brief
A Phase 4 clinical trial evaluating Otezla for Psoriasis. Completed, enrolled 50 participants across 1 site.
Detailed Summary
Add-on Enstilar to Otezla therapy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis
CountriesUnited States
CollaboratorsCelgene Corporation
Timeline
Phase 4CompletedFinished
20192020202120222023202420252026
First PostedJul 2018
Enrollment StartJul 2018
Primary CompletionJul 2019
TodayJul 2026
First PostedJul 16, 2018
Enrollment StartJul 23, 2018
Primary CompletionJul 1, 2019
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 8.0 years ago
Interventions
Otezladrug
Otezla 30mg BID